Direct-to-Consumer Genetic Testing Devices Market

Direct-to-Consumer Genetic Testing Devices
Market - Size, Share, Growth, Outlook, and
Opportunity Analysis, 2018-2026
Genetic testing is a type of medical test that determines changes in genes, chromosomes, or
proteins. The tests was available only through healthcare professionals such as doctors, nurses, and
genetic counselors. However, this trend is gradually shifting towards the customer or consumer.
Genetic testing is now offered directly at home, and is called Direct-to-Consumer (DTC) Genetic
Testing, which bypasses the mediators or facilitators such as Physicians, Genetic Counselors, and
others. The most critical thing about the genetic tests is that these tests are for disease
susceptibilities only and cannot be used alone for treatment decisions or other medical interventions.
In genetic testing, interpretation is important and is transferred to individual patient, who may not be
trained geneticist.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1046
Direct-to-Consumer (DTC) Genetic Testing is advantageous for manufacturers as it gives direct
access to them to appeal to the customer and maximize their revenue. However, this testing provides
easy access to the customer while chances of misinterpretation are really high.
The U.S. FDA has kept these tests in “Tier 3” category due to high chances of misinterpretation
of direct-to-consumer (DTC) genetic testing. According to FDA, Tier 3 category means that there
is no clinical validity or utility of such applications in healthy individuals in the population.
Easy accessibility along with increased incidences of chronic disease such as cancer,
Alzheimer’s, and Parkinson’s is expected to drive growth of the market
Genetic testing requires patients or healthy individuals to visit trained medical professionals such
as doctors, nurses or counselors, in order to get their test interpretations of the result. This
process has now become unnecessary or voluntarily with the introduction of direct-to-consumer
(DTC) genetic testing devices. This has significantly cut down the cost associated with testing
and increasing accessibility of such tests to potential patients.
Increasing awareness about health, especially in developed economies such as U.S., Canada, and
U.K. among others, and increasing incidences of chronic diseases such as cancer, Alzheimer’s,
and Parkinson’s is majorly contributing to growth of the market. The reasons for this reactiveness
varies with geography. For instance, in developed economies such as U.S. and Germany, aging
population are more prone to chronic conditions, which include cancer, neurological disorders,
and cardiovascular disorders. In 2017, FDA approved direct-to-consumer (DTC) genetic testing
for 10 diseases, including Alzheimer’s and Parkinson’s. This has further certified direct-toconsumer (DTC) genetic testing devices for these conditions, which in turn, is expected to
increase the use of direct-to-consumer (DTC) genetic tests among patients suffering from the
medical conditions.
Report includes chapters which deeply display the following deliverable about industry :
• Direct-to-Consumer Genetic Testing Devices Market Research Objective and Assumption
• Direct-to-Consumer Genetic Testing Devices Market Purview - Report Description, Executive
Summary, and Coherent Opportunity Map (COM)
• Direct-to-Consumer Genetic Testing Devices Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Direct-to-Consumer Genetic Testing Devices Market, By Regions
• Direct-to-Consumer Genetic Testing Devices Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Direct-to-Consumer Genetic Testing Devices Market Manufacturers Profiles/Analysis including
Company Basic Information, Manufacturing Base and Its Competitors.
• Direct-to-Consumer Genetic Testing Devices Market Manufacturing Cost Analysis including Key
Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Direct-to-Consumer Genetic Testing Devices Market Forecast including Production, Consumption,
Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the global direct-to-consumer genetic testing devices market
include 23andMe, Pathway Genomics, Color Genomics, Counsyl, Inc., deCode genetics,
Inc., Map My Gene, and GenePartner.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1046
Global Direct-to-Consumer Genetic Testing Devices Market Taxonomy:
By Application:
• Health Testing
• Carrier Testing (Diagnosis screening)
• Nutrigenetic Testing
• Ancestry
• Relationship Testing
• Talent Testing
• Matchmaking
• Others
By Type of Sample:
• Saliva
• Blood
• Others
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Download Report